Stanford University Licenses Ingenuity Pathways Analysis, Collaborates on Systems Biology Solutions

Stanford Genome Technology Center Will apply Ingenuity's technology to More Quickly and Comprehensively Understand the Biology Underlying Their Experimental Datasets

07-Nov-2003

Ingenuity is pleased to announce today that the Stanford Genome Technology Center at Stanford University has licensed Ingenuity Pathways Analysis, a new web-delivered application that enables biologists to discover, visualize, and explore therapeutically relevant networks significant to their experimental results.

Dr. Ronald Davis, Professor of Biochemistry and Genetics at Stanford University and Director of the Stanford Genome Technology Center, first used the application during its beta release. Dr. Davis, who is pleased with the application's novel analysis of gene expression data said, "Ingenuity Pathways Analysis is the first successful application to bring a systems biology approach to large datasets, enabling functional analysis on a genome scale. Its delivery, incredible ease-of-use, and most importantly, its biological insights, make this a necessary solution for anyone doing gene or protein based research."

In addition to licensing the Ingenuity Pathways Analysis application, Ingenuity and the Stanford Genome Technology Center are collaborating on the development of new functionality to further extend the application's capabilities and the state of the art of systems biology.

Jake Leschly, President and CEO of Ingenuity Systems stated, "We are pleased to be working with Dr. Davis and his team. Together, we will advance the field of systems biology and its practical application to everyday research challenges."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances